Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXL1OJ
|
||||
| Drug Name |
4-(4,5-dihydro-5-thioxo-1,3,4-thiadiazol-2-yl)-1-[alpha-(4-fluorophenyl)methylene]semicarbazide
|
||||
| Synonyms |
CHEMBL394750
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C10H8FN5OS2
|
||||
| Canonical SMILES |
Fc1ccc(\\C=N\\NC(=O)NC2=NNC(=S)S2)cc1
|
||||
| InChI |
InChI=1S/C10H8FN5OS2/c11-7-3-1-6(2-4-7)5-12-14-8(17)13-9-15-16-10(18)19-9/h1-5H,(H,16,18)(H2,13,14,15,17)/b12-5+
|
||||
| InChIKey |
TUIIAWLZJYEVCV-LFYBBSHMSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Carbonic anhydrase II | Target Info | [1587926] | ||
| Carbonic anhydrase IX | Target Info | [1587926] | |||
| NetPath Pathway | IL4 Signaling Pathway | ||||
| EGFR1 Signaling Pathway | |||||
| Pathway Interaction Database | HIF-1-alpha transcription factor network | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.